Submitted by aabolina on Mon, 11/24/2014 - 15:23
Overweight and obesity, labels for ranges of weight that are not considered healthy, are not the only causes of type 2 diabetes, but they are the most important modifiable risk factors for the condition. They are also the reason why type 2 diabetes has transformed from a problem for older adults into a global epidemic affecting all ages.
Submitted by aabolina on Mon, 11/24/2014 - 15:06
According to the American Diabetes Association (ADA), the complexity of nutrition issues in type 2 diabetes care warrants the use of a skilled and registered dietician to implement nutrition therapy into individualised diabetes management and education.1 Today, however, people with type 2 diabetes are becoming a larger part of practices of primary care clinicians, and may not always have access to a specialised nutritionist o
Submitted by aabolina on Thu, 08/28/2014 - 13:02
To what extent, if at all, should blood glucose self-monitoring be recommended for people with type 2 diabetes not treated with insulin? We have asked two experts to comment.
Submitted by aabolina on Thu, 08/28/2014 - 12:57
Submitted by aabolina on Thu, 08/28/2014 - 12:49
The first time Dr Santosh Gupta visited a rural hospital in Northern India she was shocked to learn that none of the children with type 1 diabetes survived the disease to adulthood and that people with type 2 diabetes endured inadequate care resulting in life-altering complications.
Submitted by aabolina on Thu, 08/28/2014 - 10:24
The prevalence and magnitude of childhood obesity are increasing dramatically. Until two decades ago, symptomatic children and adolescents were automatically diagnosed with type 1 diabetes. In the 1990s, type 2 diabetes in children and adolescents emerged in association with the epidemic of childhood obesity, disproportionally affecting disadvantaged minority children.
Submitted by aabolina on Wed, 02/26/2014 - 11:46
Submitted by aabolina on Wed, 02/26/2014 - 11:36
More and more frequently insulin is being recommended as an ‘add-on’ to oral hypoglycaemic therapy for the achievement of blood glucose targets in people with established type 2 diabetes. Indeed, there are now trials of insulin therapy in type 2 diabetes from diagnosis. Concerns have been raised in the recent medical literature that long-term insulin therapy in type 2 diabetes increases the risk of cardiovascular disease and some cancers. We have asked specialists in the fields of clinical diabetes and pharmacoepidemiology to comment on the question:
Submitted by aabolina on Wed, 02/26/2014 - 11:30
Submitted by aabolina on Wed, 02/26/2014 - 11:11